11026. A Phase III Randomized, Placebo-Controlled, Clinical Trial to Study the Safety and Efficacy of V212 in Adult Patients with Solid Tumor or Hematologic Malignancy
Esther Rehmus, MD
McDowell Cancer Research at 330-344-6348
Akron General Medical Center 400 Wabash Avenue Akron, OH 44307 330-344-6000 1-800-221-4601 © 2013 Akron General Health System
This site complies with the HONcode standard for trustworthy health information: verify here.